Liu[68] found that miR-181a can inhibit the activation of TLR/NF-KB signal pathway by down-regulating the level of target gene CRY1, delay the progression of glomerulosclerosis and tubular epithelial injury in chronic kidney disease, reduce the degree of renal injury and promote renal homeostasis. Here, CRY1 is linked to glomerulosclerosis.